Research is growing into computational models that will move medicine beyond what works on the average patient
Imagine having a digital twin that gets ill, and can be experimented on to identify the best possible treatment, without you having to go near a pill or a surgeon’s knife. Scientists believe that within five to 10 years, “in silico” trials – in which hundreds of virtual organs are used to assess the safety and efficacy of drugs – could become routine, while patient-specific organ models could be used to personalise treatment and avoid medical complications.
Digital twins are computational models of physical objects or processes, updated using data from their real-world counterparts. Within medicine, this means combining vast amounts of data about the workings of genes, proteins, cells and whole-body systems with patients’ personal data to create virtual models of their organs – and eventually, potentially their entire body.
About Author
More Stories
52 tiny annoying problems, solved! (Because when you can’t control the big stuff, start small)
Chinese tech firms freeze AI tools in crackdown on exam cheats
US arrests another Chinese scientist for allegedly smuggling biological material